A protein implicated in neurodegenerative diseases including amyotrophic lateral sclerosis prevents the activation of an innate immune response that leads to cell death, Vanderbilt researchers have discovered.
A drug combination effectively killed aggressive blood cancers in cell and animal models; now it’s being tested in patients.
Vanderbilt investigators have linked a specific form of programmed cell death to myelodysplastic syndrome, a type of bone marrow failure.
A novel PET imaging probe detects tumor cell death in vivo and could be useful for personalizing cancer medicine.
Death of oligodendrocytes, the cells that make myelin, appears to be an early event in the development of multiple sclerosis.
The protein SARM appears to protect cells from inflammation-driven death by stabilizing the nuclear laminin scaffold.
Accessibility Tools